Springer Nature is a leading global scientific, technical and medical portfolio, providing researchers with quality content through innovative products and services from trusted brands like Springer, Nature Portfolio, and BMC. Springer Nature has one of the strongest STM and HSS eBook collections and a comprehensive range of hybrid and open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display. | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit our booth to learn about publishing with us. | Springer Nature is a leading global research, educational and professional publisher, home to an array of trusted brands, including Springer, Nature Portfolio, Palgrave Macmillan, BioMed Central, and Scientific American. We provide quality content for the Genetics community through innovative products and services, extensive eBook collections, and hybrid/open access journals across the sciences and humanities. Meet with our editors to learn about the benefits of publishing with us. Find out more: www.springernature.com | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit springernature.com and @SpringerNature. | Springer Nature is one of the world’s leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature advances discovery by publishing trusted research, supporting the development of new ideas and championing open science. We are committed to playing our part in accelerating solutions to address the world’s urgent challenges. The newest addition to the Springer Nature family of products is protocols.io, a secure platform for developing, optimizing, sharing, and running reproducible research methods. | Springer Nature Information and insights to drive research, development and excellence Fuel your innovation pipeline and improve commercial outcomes with Springer Nature’s comprehensive portfolio of content and solutions. With over 150 years of expertise in scientific publishing, we are a trusted partner to life sciences organizations, providing the insights, data and platforms needed to accelerate research, enhance decision-making, and drive business success. Our solutions empower biopharma and biotech professionals to stay ahead in a rapidly evolving industry: AdisInsight Make confident decisions in drug development In the fast-paced world of biopharma, every decision counts. AdisInsight provides trusted, expertly curated intelligence on drug development, clinical trials, deals and safety, empowering you to act with certainty. Stay Ahead: Updated daily with the latest drug and trial data. Trust Your Data: Expert-validated insights with full transparency on sources. Seamless Integration: Plug directly into your internal analytics for deeper insights. Strategic Advantage: Identify opportunities, track competitors and accelerate decision-making. Navigate drug development with confidence with AdisInsight. adisinsight.springer.com Biopharma Dealmakers Make biopharma connections today Biopharma Dealmakers is the premier platform connecting life sciences innovators, investors and pharma leaders. Get exclusive deal insights, funding trends and opportunities to showcase your company. Trusted Industry Insights: Editorial coverage on M&A, licensing, and funding. Global Reach: Distributed with Nature Biotechnology and Nature Reviews Drug Discovery. Partnering Opportunities: Feature your company’s assets, innovations and investment needs. Branded Content: Tailored campaigns to position your company in front of the right audience. Connect, partner and accelerate your next deal with Biopharma Dealmakers. nature.com/biopharmdeal protocols.io Accelerate innovation with reproducible research protocols.io is a secure, interactive platform for developing and sharing research methods, ensuring standardization, collaboration, and compliance. Reproducibility First: Step-by-step protocols with version tracking. Seamless Collaboration: Share, comment, and refine methods in real time. Compliance-Ready: Supports HIPAA and 21 CFR Part 11 compliance. Institutional Knowledge: Preserve protocols and expertise within your organization. Streamline research and ensure reproducibility with protocols.io. protocols.io Nature Portfolio Engage the STEM community with impact Reach a global community of scientists, healthcare professionals and decision-makers with Nature Portfolio’s advertising and content solutions. Unmatched Reach: 55M monthly users, 6.5M newsletter subscribers, 100K podcast listeners. Precision Targeting: Data-driven campaigns for maximum engagement. Multi-Channel Advertising: Digital, print, email and podcast options. Branded Content: Award-winning storytelling aligned with Nature’s trusted voice. Align your brand with scientific excellence—partner with Nature Portfolio. partnerships.nature.com Text and Data Mining (TDM) With the ever-expanding volume of valuable information becoming available daily, any fragment of it could hold the key to the next breakthrough. By analysing this information, and uncovering patterns and trends, you can get the insights you need to fast-track innovation. By choosing Springer Nature’s API as your data source, you’ll have access to our extensive collection of high-quality groundbreaking research, across all subject areas. All of our data is from a trusted, peer-reviewed content source, giving you information you can trust and ultimately leading to higher quality output. You can apply our data to meet a limitless range of business goals, from understanding trending topics to finding potential collaborators to building new products. Data Solutions (TDM) | Springer Nature is a leading global scientific, technical and medical publisher, providing researchers with innovative information, products and services. | Springer is a leading global research publisher, providing researchers with quality Radiology content through innovative information, products and services. As part of Springer Nature, Springer sits alongside other trusted brands like Nature Portfolio and BMC to provide a comprehensive range of books, eBook collections, and hybrid/open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display.
PAREXEL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.
Nationwide Children’s Hospital
The Division of Pulmonary, Sleep Medicine and Cystic Fibrosis at Nationwide Children’s Hospital provides the highest quality clinical care for children and adults with congenital respiratory disorders, including cystic fibrosis, advanced lung disease, sleep-related breathing disorders and more. Our providers care for patients approaching and following lung/heart-lung transplant and those managing long-term mechanical ventilation. We are proud of the care we provide to children with respiratory disease, and this was acknowledged again this year by U.S. News & World Report as we have remained a top 10 pediatric pulmonary department since 2012! | At Nationwide Children’s Hospital, we understand the importance of translating innovative work beyond our walls and into the world. New technologies drive economic development in our local, national, and global ecosystem and most importantly, improve pediatric care. The Office of Technology Commercialization exists to ensure that the necessary partnerships are in place to execute this important function. Nationwide Children’s Hospital is one of America’s largest pediatric hospitals, an international leader in research, and is ranked in all 10 specialties on U.S. News & World Report’s 2023-24 “America’s Best Children’s Hospitals” list. In addition, according to the Children’s Hospital Association, Nationwide Children’s is the #1 provider of pediatric surgery in the country. The Abigail Wexner Research Institute at Nationwide Children’s Hospital has earned its reputation as an institution with a remarkable track record of moving discoveries into the marketplace. The hospital’s innovators, stationed in more than 800,000 square feet of dedicated research space, are committed to enhancing the health of children by engaging in high-quality, cutting-edge research according to the highest scientific and ethical standards while advancing life-saving therapies to children everywhere. The Office of Technology Commercialization at Nationwide Children’s guides ideas to solutions by offering expertise in technology transfer and facilitating partnerships between inventors and industry to bring discoveries to patients, clinicians and scientists around the world. Our resourceful team guides Nationwide Children’s clinicians, researchers, and partners through complex processes with creative solutions. This ranges from therapeutics, biomarkers, diagnostic tools, research and clinical tools, and medical devices. Some of our successes include first-of-their-kind gene therapies, Zolgensma and Elevidys – FDA-approved treatments for Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD) – and medical devices like the Comfort Collar or the Endoscopic Retrieval Device. Nationwide Children’s Hospital, located in Columbus, Ohio and with over 16,000 employees, is leading a bold journey to best outcomes for children everywhere. | The Nationwide Children’s Hospital Office of Technology Commercialization (OTC) guides ideas to solutions by offering expertise in technology transfer and facilitating partnerships between inventors and industry to bring discoveries to patients, clinicians and scientists around the world. Our resourceful team guides inventors and partners through complex processes with creative solutions. This ranges from therapeutics, including the approved, first-of-their-kind gene therapies – Zolgensma and Elevidys, FDA-approved treatments for Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD) – to biomarkers, diagnostic tools and clinical tools – such as the Comfort Collar, designed to prevent pressure wounds around tracheostomy tubes – to outside partners to benefit patients, the local community and the general public. As a result, the Abigail Wexner Research Institute at Nationwide Children’s Hospital has earned its reputation as an institution with a remarkable track record of moving discoveries into the marketplace. The hospital’s physicians and researchers are dedicated to enhancing the health of children by engaging in high-quality, cutting-edge research according to the highest scientific and ethical standards while advancing life-saving therapies to children everywhere. We encourage all interested entrepreneurs and potential licensing partners to stop by the Ohio Pavilion (Booth No. 1865) to discuss our many available preclinical and clinical technologies, ranging from early-stage innovations to market-ready products. Our portfolio of over 200 available technologies developed by our innovative researchers and clinicians at Nationwide Children’s Hospital is diverse and ever-growing. | The Office of Technology Commercialization (OTC) at Nationwide Children’s Hospital supports the translation of innovative research into real-world healthcare solutions. Working closely with clinicians, researchers, and industry partners, OTC advances intellectual property development, licensing, and startup formation to bring pediatric-focused technologies to market. OTC also collaborates closely with the Nationwide Children’s Innovation Center to foster cross-disciplinary innovation and accelerate the development of novel solutions from concept through commercialization. Nationwide Children’s Hospital is consistently ranked among the top 10 children’s hospitals in the nation by U.S. News & World Report, earning the “Honor Roll” distinction for 12 consecutive years as of 2025. It is also the #1 ranked pediatric hospital in Ohio and the Midwest and is consistently among the top NIH-funded pediatric research institutions in the United States, reflecting its national leadership in biomedical discovery and translational science. Together, Nationwide Children’s, the OTC and Innovation Center drive collaboration and commercialization efforts that accelerate the development of life-changing therapies, devices, and diagnostics for children worldwide.
National Jewish Health Advanced Diagnostic Laboratories
National Jewish Health Advanced Diagnostic Laboratories provides unparalleled expertise in immune and respiratory disease to our clinical, biotech, pharmaceutical, public health and diagnostic partners. Our high complexity, CLIA and CAP15189-certified laboratories have decades of experience developing immunology, complement, infectious disease and molecular genomic tests. Our world-renowned scientists are committed to providing the highest quality specialized laboratory services. Visit us at Booth 1026 to learn about our TRIKAFTKA drug monitoring test, Alpha-1 genomic panel and more. Njlabs.org
National Disease Research Interchange (NDRI)
For 40 years, National Disease Research Interchange has revolutionized the progress of scientific research by partnering with organ and tissue donation programs to procure and distribute human biospecimens to biomedical researchers. The National Institutes of Health has provided funding to NDRI since 1987. Partnering for Progress Researchers in academic medical centers, non-profit research organizations, as well as pharmaceutical, biotechnology, and medical device companies rely on NDRI for access to quality human biospecimens.
Monaghan Medical Corporation
Monaghan Medical Corporation (MMC), headquartered in Plattsburgh, New York, offers leading aerosol drug delivery devices and respiratory management products including the AeroEclipse® II BAN, AeroChamber® Brand of VHC and the Aerobika® OPEP device exclusively in the United States. MMC focuses on developing cost-efficient, outcome-based solutions for its customers. www.monaghanmed.com